| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | FOXO3 ATF7 ASXL1 TCF3 TCF12 BCAS3 PCLO NACA SALL4 KAT2A RUNX2 MED1 BCOR RXRA RXRB NCOR2 ARNT PER3 NFATC1 ARID2 KMT2A DOT1L BSN MED12 MED13 TP53BP1 | 1.86e-14 | 753 | 107 | 26 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | ASXL1 TCF3 TCF12 BCAS3 KAT2A RUNX2 MED1 BCOR RXRA RXRB NCOR2 ARNT NFATC1 KMT2A DOT1L MED12 MED13 TP53BP1 | 1.85e-09 | 582 | 107 | 18 | GO:0140297 |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 3.26e-08 | 18 | 107 | 5 | GO:0042809 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | IRF2BP2 ASXL1 NACA KAT2A MED1 BCOR SSBP3 RXRB NCOR2 DOT1L KAT6B MAML3 MED12 MED13 TP53BP1 | 3.17e-07 | 562 | 107 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | ASXL1 TCF3 BCAS3 MED1 RXRA RXRB NCOR2 ARNT NFATC1 DOT1L MED12 MED13 TP53BP1 | 3.65e-07 | 417 | 107 | 13 | GO:0061629 |
| GeneOntologyMolecularFunction | chromatin binding | FOXO3 ASXL1 TSHZ3 TCF3 BCAS3 KAT2A EYA3 RUNX2 MED1 RXRA RXRB NCOR2 NFATC1 KMT2A KAT6B TCF7L1 MED12 | 3.93e-07 | 739 | 107 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coactivator activity | ASXL1 NACA KAT2A MED1 SSBP3 RXRB DOT1L KAT6B MAML3 MED12 MED13 | 6.97e-07 | 303 | 107 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 8.68e-07 | 140 | 107 | 8 | GO:0001221 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 9.89e-07 | 34 | 107 | 5 | GO:0046966 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 7.53e-06 | 187 | 107 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 8.22e-06 | 8 | 107 | 3 | GO:0098882 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.13e-05 | 55 | 107 | 5 | GO:0042974 | |
| GeneOntologyMolecularFunction | vitamin D response element binding | 8.50e-05 | 3 | 107 | 2 | GO:0070644 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.01e-04 | 54 | 107 | 4 | GO:0001223 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 3.22e-04 | 61 | 107 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | IRF2BP2 ASXL1 NACA KAT2A MED1 BCOR SSBP3 RXRB NCOR2 PXN DOT1L KAT6B MAML3 MED12 MED13 TP53BP1 | 4.44e-04 | 1160 | 107 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | beta-catenin binding | 4.70e-04 | 120 | 107 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXO3 ATF7 TSHZ3 TCF3 TCF12 ZBTB47 SALL4 RUNX2 FOXI3 RXRA RXRB TFE3 OTP ARNT SALL2 NFATC1 YLPM1 TCF7L1 | 4.88e-04 | 1412 | 107 | 18 | GO:0000981 |
| GeneOntologyMolecularFunction | retinoic acid-responsive element binding | 5.87e-04 | 7 | 107 | 2 | GO:0044323 | |
| GeneOntologyMolecularFunction | LBD domain binding | 5.87e-04 | 7 | 107 | 2 | GO:0050693 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXO3 ATF7 TCF3 TCF12 SALL4 RUNX2 MED1 BCOR FOXI3 RXRA RXRB TFE3 OTP ARNT SALL2 NFATC1 TCF7L1 MED12 | 7.17e-04 | 1459 | 107 | 18 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXO3 ATF7 TCF3 TCF12 SALL4 RUNX2 MED1 FOXI3 RXRA RXRB TFE3 ARNT SALL2 NFATC1 TCF7L1 MED12 | 9.43e-04 | 1244 | 107 | 16 | GO:0000978 |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.02e-03 | 37 | 107 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXO3 ATF7 TCF3 TCF12 SALL4 RUNX2 MED1 FOXI3 RXRA RXRB TFE3 ARNT SALL2 NFATC1 TCF7L1 MED12 | 1.18e-03 | 1271 | 107 | 16 | GO:0000987 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.48e-03 | 42 | 107 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | cAMP response element binding | 1.81e-03 | 12 | 107 | 2 | GO:0035497 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.06e-03 | 167 | 107 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | vinculin binding | 2.13e-03 | 13 | 107 | 2 | GO:0017166 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 2.29e-03 | 103 | 107 | 4 | GO:0004725 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | IRF2BP2 ASXL1 NACA KAT2A MED1 BCOR SSBP3 RXRB NCOR2 PXN DOT1L KAT6B MAML3 MED12 MED13 TP53BP1 | 2.30e-03 | 1356 | 107 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.85e-03 | 15 | 107 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 3.91e-03 | 59 | 107 | 3 | GO:0001222 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 4.10e-03 | 60 | 107 | 3 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 4.30e-03 | 61 | 107 | 3 | GO:0098531 | |
| GeneOntologyMolecularFunction | E-box binding | 4.30e-03 | 61 | 107 | 3 | GO:0070888 | |
| GeneOntologyMolecularFunction | lamin binding | 4.58e-03 | 19 | 107 | 2 | GO:0005521 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 4.91e-03 | 599 | 107 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 4.92e-03 | 64 | 107 | 3 | GO:0140296 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 5.59e-03 | 21 | 107 | 2 | GO:0042975 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXO3 ATF7 ASXL1 TCF3 TCF12 BCAS3 NACA SALL4 TLR7 KAT2A RUNX2 MED1 SSBP3 RXRA RXRB TFE3 ARNT SALL2 NFATC1 ARID2 KMT2A DOT1L KAT6B TCF7L1 MAML3 MED12 PCK1 MED13 TP53BP1 | 5.83e-11 | 1390 | 107 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | embryo development | ATF7 TSHZ3 TCF3 CECR2 AFF3 SALL4 KAT2A RUNX2 MED1 BCOR SSBP3 FOXI3 INO80D RXRA RXRB NCOR2 ARNT SALL2 ARID2 KMT2A TCF7L1 MED12 PRRC2B | 1.01e-06 | 1437 | 107 | 23 | GO:0009790 |
| GeneOntologyBiologicalProcess | chordate embryonic development | ATF7 TSHZ3 CECR2 SALL4 KAT2A RUNX2 MED1 BCOR SSBP3 FOXI3 RXRA RXRB NCOR2 ARNT SALL2 MED12 PRRC2B | 4.08e-06 | 906 | 107 | 17 | GO:0043009 |
| GeneOntologyBiologicalProcess | hemopoiesis | FOXO3 ATF7 IRF2BP2 ASXL1 TCF3 IL15RA KAT2A RUNX2 MED1 SSBP3 TFE3 ADD2 ARNT MS4A1 NFATC1 PTPRZ1 ARID2 KMT2A KAT6B PCK1 | 4.21e-06 | 1223 | 107 | 20 | GO:0030097 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | ATF7 TSHZ3 CECR2 SALL4 KAT2A RUNX2 MED1 BCOR SSBP3 FOXI3 RXRA RXRB NCOR2 ARNT SALL2 MED12 PRRC2B | 5.69e-06 | 929 | 107 | 17 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of vitamin D receptor signaling pathway | 1.59e-05 | 10 | 107 | 3 | GO:0070562 | |
| GeneOntologyBiologicalProcess | vitamin D receptor signaling pathway | 2.89e-05 | 12 | 107 | 3 | GO:0070561 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FOXO3 ATF7 IRF2BP2 TSHZ3 TCF3 NACA SALL4 KAT2A RUNX2 MED1 BCOR RXRA NCOR2 OTP SALL2 PER3 NFATC1 YLPM1 KAT6B TCF7L1 | 3.01e-05 | 1399 | 107 | 20 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FOXO3 ATF7 IRF2BP2 TSHZ3 TCF3 NACA SALL4 KAT2A RUNX2 MED1 BCOR RXRA NCOR2 OTP SALL2 PER3 NFATC1 YLPM1 KAT6B TCF7L1 | 3.47e-05 | 1413 | 107 | 20 | GO:1902679 |
| GeneOntologyBiologicalProcess | heart development | ATF7 ASXL1 DSP NACA SALL4 KAT2A MED1 BCOR RXRA RXRB NCOR2 NFATC1 ARID2 MED12 | 3.68e-05 | 757 | 107 | 14 | GO:0007507 |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 7.97e-05 | 3 | 107 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | FOXO3 ATF7 IRF2BP2 TCF3 NACA SALL4 KAT2A MED1 BCOR RXRA NCOR2 OTP SALL2 PER3 NFATC1 YLPM1 | 1.03e-04 | 1053 | 107 | 16 | GO:0000122 |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | FOXO3 IRF2BP2 TCF3 IL15RA KAT2A RUNX2 MS4A1 NFATC1 ARID2 KMT2A PCK1 | 1.09e-04 | 537 | 107 | 11 | GO:0030098 |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | FOXO3 IRF2BP2 TCF3 IL15RA KAT2A RUNX2 MED1 MS4A1 NFATC1 ARID2 KMT2A PCK1 | 1.21e-04 | 640 | 107 | 12 | GO:1903131 |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 1.59e-04 | 4 | 107 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | epithelium development | ASXL1 TSHZ3 DSP CECR2 PUM2 SALL4 KAT2A MED1 SSBP3 FOXI3 RXRA NCOR2 OTP SALL2 NFATC1 PXN DMD MED12 PCK1 | 1.84e-04 | 1469 | 107 | 19 | GO:0060429 |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 1.94e-04 | 161 | 107 | 6 | GO:0003231 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | ASXL1 TCF3 CECR2 KAT2A EYA3 MED1 BCOR UBN2 INO80D ARID2 KMT2A DOT1L KAT6B TCF7L1 TP53BP1 | 1.98e-04 | 999 | 107 | 15 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | ASXL1 TCF3 CECR2 KAT2A EYA3 BCOR UBN2 INO80D ARID2 KMT2A DOT1L KAT6B TCF7L1 TP53BP1 | 2.19e-04 | 896 | 107 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 2.23e-04 | 23 | 107 | 3 | GO:0071305 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | FOXO3 IRF2BP2 TCF3 IL15RA KAT2A RUNX2 MED1 TFE3 MS4A1 NFATC1 ARID2 KMT2A PCK1 | 2.24e-04 | 789 | 107 | 13 | GO:0002521 |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 2.64e-04 | 5 | 107 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | ATF7 TSHZ3 SALL4 KAT2A MED1 BCOR RXRA RXRB NCOR2 ARNT PRRC2B | 2.70e-04 | 596 | 107 | 11 | GO:0001701 |
| GeneOntologyBiologicalProcess | heart morphogenesis | 2.71e-04 | 321 | 107 | 8 | GO:0003007 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 3.18e-04 | 416 | 107 | 9 | GO:0030522 | |
| GeneOntologyBiologicalProcess | positive regulation of vitamin D receptor signaling pathway | 3.95e-04 | 6 | 107 | 2 | GO:0070564 | |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 3.95e-04 | 6 | 107 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | peroxisome proliferator activated receptor signaling pathway | 4.05e-04 | 28 | 107 | 3 | GO:0035357 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin | 5.49e-04 | 31 | 107 | 3 | GO:0071295 | |
| GeneOntologyCellularComponent | transcription regulator complex | FOXO3 ATF7 TCF3 TCF12 SALL4 KAT2A EYA3 RUNX2 MED1 SSBP3 RXRA RXRB TFE3 NCOR2 ARNT NFATC1 ARID2 TCF7L1 | 1.32e-09 | 596 | 107 | 18 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | FOXO3 ATF7 TSHZ3 TCF3 TCF12 BCAS3 CECR2 SALL4 KAT2A RUNX2 MED1 INO80D RXRA RXRB TFE3 NCOR2 OTP ARNT NFATC1 ARID2 TMPO KAT6B TCF7L1 | 1.33e-06 | 1480 | 107 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | FOXO3 ATF7 ASXL1 TCF3 TCF12 CECR2 AFF3 TSEN54 KAT2A MED1 BCOR INO80D RXRA RXRB NCOR2 ARNT ARID2 KMT2A TCF7L1 MED12 MED13 | 5.61e-06 | 1377 | 107 | 21 | GO:0140513 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.10e-05 | 272 | 107 | 9 | GO:0090575 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.14e-04 | 23 | 107 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | CKM complex | 2.57e-04 | 5 | 107 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 7.12e-04 | 8 | 107 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | mediator complex | 8.93e-04 | 37 | 107 | 3 | GO:0016592 | |
| MousePheno | abnormal head morphology | CCP110 ASXL1 DSP BCAS3 C3orf38 CECR2 KIAA0586 AFF3 CKAP5 SALL4 KAT2A RUNX2 MED1 BCOR SSBP3 FOXI3 UBN2 ARNT SLC24A4 KMT2A KAT6B MED12 | 2.49e-06 | 1120 | 92 | 22 | MP:0000432 |
| MousePheno | abnormal cardiovascular development | CCP110 BCAS3 KIAA0586 SALL4 KAT2A RUNX2 MED1 BCOR RXRA NCOR2 ARNT NFATC1 ADAMTS7 ARID2 PXN DOT1L MED12 PRRC2B | 3.96e-06 | 802 | 92 | 18 | MP:0002925 |
| MousePheno | abnormal cell proliferation | FOXO3 ASXL1 TCF3 IL15RA NACA SALL4 CDHR5 TLR7 KAT2A RUNX2 MED1 BCOR SSBP3 RXRA CD300C NCOR2 ADAMTS7 ARID2 TMPO KMT2A DMD DOT1L TP53BP1 | 7.52e-06 | 1294 | 92 | 23 | MP:0000350 |
| MousePheno | abnormal synaptic vesicle number | 7.77e-06 | 42 | 92 | 5 | MP:0004792 | |
| MousePheno | abnormal embryonic tissue morphology | CCP110 DSP BCAS3 CECR2 KIAA0586 SALL4 KAT2A MED1 BCOR SSBP3 FOXI3 RXRA ARNT SALL2 NFATC1 YLPM1 PXN KMT2A TCF7L1 MED12 PRRC2B | 8.68e-06 | 1116 | 92 | 21 | MP:0002085 |
| MousePheno | abnormal synaptic vesicle morphology | 2.05e-05 | 51 | 92 | 5 | MP:0004769 | |
| MousePheno | embryonic lethality during organogenesis | DSP BCAS3 KIAA0586 NACA SALL4 KAT2A MED1 BCOR SSBP3 FOXI3 ARNT ARID2 PXN KMT2A DOT1L TCF7L1 MED12 | 4.97e-05 | 876 | 92 | 17 | MP:0006207 |
| MousePheno | abnormal sternebra number | 7.52e-05 | 13 | 92 | 3 | MP:0012282 | |
| MousePheno | increased double-negative T cell number | 8.92e-05 | 69 | 92 | 5 | MP:0005090 | |
| MousePheno | abnormal craniofacial morphology | CCP110 ASXL1 DSP C3orf38 CECR2 KIAA0586 AFF3 CKAP5 SALL4 RUNX2 SSBP3 FOXI3 UBN2 RXRA NCOR2 ARNT SLC24A4 KMT2A KAT6B MED12 PRRC2B | 1.81e-04 | 1372 | 92 | 21 | MP:0000428 |
| MousePheno | craniofacial phenotype | CCP110 ASXL1 DSP C3orf38 CECR2 KIAA0586 AFF3 CKAP5 SALL4 RUNX2 SSBP3 FOXI3 UBN2 RXRA NCOR2 ARNT SLC24A4 KMT2A KAT6B MED12 PRRC2B | 1.81e-04 | 1372 | 92 | 21 | MP:0005382 |
| Domain | Znf_piccolo | 3.25e-05 | 2 | 107 | 2 | IPR008899 | |
| Domain | zf-piccolo | 3.25e-05 | 2 | 107 | 2 | PF05715 | |
| Domain | AT_hook | 9.70e-05 | 16 | 107 | 3 | PF02178 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS | 1.44e-06 | 5 | 75 | 3 | M29812 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 2.86e-06 | 6 | 75 | 3 | MM15663 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.99e-06 | 118 | 75 | 7 | M27316 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 5.42e-06 | 84 | 75 | 6 | M1008 | |
| Pathway | PID_RXR_VDR_PATHWAY | 1.01e-05 | 26 | 75 | 4 | M162 | |
| Pathway | WP_ECTODERM_DIFFERENTIATION | 1.02e-05 | 142 | 75 | 7 | M39575 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 1.19e-05 | 9 | 75 | 3 | M29809 | |
| Pathway | REACTOME_ADIPOGENESIS | 2.56e-05 | 110 | 75 | 6 | M48259 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 3.98e-05 | 13 | 75 | 3 | MM15622 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 7.39e-05 | 82 | 75 | 5 | M2 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.11e-04 | 47 | 75 | 4 | M29777 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.11e-04 | 18 | 75 | 3 | MM15034 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.20e-04 | 48 | 75 | 4 | M288 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.20e-04 | 48 | 75 | 4 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.78e-04 | 53 | 75 | 4 | M8276 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | FOXO3 TCF3 TCF12 KAT2A RUNX2 MED1 RXRA RXRB NCOR2 ARNT KMT2A TCF7L1 MAML3 | 1.85e-04 | 768 | 75 | 13 | MM14851 |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.37e-04 | 23 | 75 | 3 | MM14954 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE | 2.76e-04 | 5 | 75 | 2 | M29791 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE | 2.76e-04 | 5 | 75 | 2 | M29792 | |
| Pathway | KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION | 2.76e-04 | 5 | 75 | 2 | M49023 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 3.44e-04 | 26 | 75 | 3 | M47439 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 4.13e-04 | 6 | 75 | 2 | M48097 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 4.13e-04 | 6 | 75 | 2 | MM1447 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 4.31e-04 | 28 | 75 | 3 | M48253 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 4.31e-04 | 28 | 75 | 3 | M6177 | |
| Pathway | KEGG_THYROID_CANCER | 4.78e-04 | 29 | 75 | 3 | M523 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 5.30e-04 | 30 | 75 | 3 | M207 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 5.76e-04 | 7 | 75 | 2 | MM1573 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 5.76e-04 | 7 | 75 | 2 | M6907 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.66e-04 | 8 | 75 | 2 | M22058 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | FOXO3 TCF3 TCF12 KAT2A RUNX2 MED1 RXRA RXRB NCOR2 ARNT ARID2 KMT2A TCF7L1 MAML3 MED12 PCK1 MED13 | 8.11e-04 | 1387 | 75 | 17 | M734 |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 9.81e-04 | 9 | 75 | 2 | M29789 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 9.81e-04 | 9 | 75 | 2 | M47629 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 9.87e-04 | 37 | 75 | 3 | M29790 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | FOXO3 TCF3 TCF12 DSP SALL4 KAT2A MED1 RXRA TFE3 NCOR2 KMT2A TCF7L1 MAML3 MED12 PCK1 MED13 CNTN2 | 1.16e-03 | 1432 | 75 | 17 | M509 |
| Pathway | WP_VITAMIN_D_METABOLISM | 1.22e-03 | 10 | 75 | 2 | M39352 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.22e-03 | 10 | 75 | 2 | MM15535 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 1.49e-03 | 11 | 75 | 2 | M18837 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 1.49e-03 | 11 | 75 | 2 | MM1432 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.66e-03 | 161 | 75 | 5 | M27871 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.70e-03 | 96 | 75 | 4 | M27784 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.75e-03 | 45 | 75 | 3 | M39571 | |
| Pathway | PID_ILK_PATHWAY | 1.75e-03 | 45 | 75 | 3 | M71 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 1.83e-03 | 98 | 75 | 4 | M48247 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.86e-03 | 46 | 75 | 3 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.98e-03 | 47 | 75 | 3 | M7946 | |
| Pathway | WP_ENERGY_METABOLISM | 2.11e-03 | 48 | 75 | 3 | M39590 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.11e-03 | 48 | 75 | 3 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 2.24e-03 | 49 | 75 | 3 | M48250 | |
| Pubmed | IRF2BP2 ASXL1 TSHZ3 TCF3 TCF12 CDC42BPA NACA PUM2 KAT2A EYA3 BCOR SSBP3 ANKHD1 UBN2 INO80D RXRA TFE3 KIAA1671 NCOR2 ARNT SALL2 ARID2 YLPM1 KMT2A DOT1L TP53BP1 PRRC2B | 2.48e-14 | 1429 | 108 | 27 | 35140242 | |
| Pubmed | DSP MED1 BCOR ANKHD1 UBN2 KIAA1671 EPS15L1 PTPN13 ARID2 YLPM1 SEC23IP TMPO KMT2A DOT1L MED12 TP53BP1 PRRC2B | 1.34e-12 | 549 | 108 | 17 | 38280479 | |
| Pubmed | ATF7 IRF2BP2 TCF3 TCF12 CKAP5 ZNF207 KAT2A EYA3 RUNX2 MED1 BCOR UBN2 INO80D NCOR2 ARNT ARID2 TMPO KMT2A MED12 TP53BP1 PRRC2B | 2.50e-11 | 1103 | 108 | 21 | 34189442 | |
| Pubmed | FOXO3 ATF7 TCF12 ZNF207 SALL4 KAT2A RUNX2 RXRA RXRB TFE3 ZCCHC14 ARNT PER3 NFATC1 ARID2 PXN KAT6B TCF7L1 | 6.36e-11 | 808 | 108 | 18 | 20412781 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | IRF2BP2 DSP NACA CKAP5 PUM2 MED1 BCOR ANKHD1 KIAA1671 EPS15L1 PTPN13 ARID2 YLPM1 SEC23IP TMPO KMT2A JPT2 TP53BP1 PRRC2B | 8.24e-11 | 934 | 108 | 19 | 33916271 |
| Pubmed | CBLL1 CCP110 TSHZ3 CTTNBP2 DSP KIAA0586 AFF3 PEX13 ZNF207 RIPOR3 SALL4 RUNX2 RXRA ADD2 ZCCHC14 NCOR2 ARID2 TNK2 MED13 CNTN2 PRRC2B | 1.47e-10 | 1215 | 108 | 21 | 15146197 | |
| Pubmed | CECR2 PCLO NACA ZBTB47 MUC16 SALL4 BCOR SSBP3 NCOR2 SALL2 TCF7L1 PRRC1 TP53BP1 | 3.45e-10 | 396 | 108 | 13 | 26687479 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CCP110 DSP EYA3 BCOR UBN2 KIAA1671 NCOR2 ARNT SALL2 NFATC1 ARID2 DOT1L BSN TP53BP1 PRRC2B | 4.56e-10 | 588 | 108 | 15 | 38580884 |
| Pubmed | TCF3 TCF12 ZNF207 KAT2A RXRA RXRB TFE3 ZCCHC14 OTP ARNT SALL2 PXN KMT2A KAT6B TCF7L1 MAML3 | 6.73e-10 | 709 | 108 | 16 | 22988430 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 CDC42BPA BCAS3 NTSR1 KAT2A ANKHD1 TFE3 CCDC142 ZCCHC14 NCOR2 EPS15L1 NFATC1 ADAMTS7 PXN TNK2 DOT1L MED12 MED13 PRRC2B | 1.35e-09 | 1105 | 108 | 19 | 35748872 |
| Pubmed | TSHZ3 DSP CKAP5 BCOR ANKHD1 KIAA1671 NCOR2 PTPN13 SALL2 SEC23IP PXN MED12 | 7.66e-09 | 418 | 108 | 12 | 34709266 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 CCP110 STIM2 CDC42BPA DSP BCAS3 CKAP5 PARD3B PLEKHG2 KIAA1671 ZCCHC14 VPS13D PTPN13 MAP3K9 KMT2A PRRC1 | 1.06e-08 | 861 | 108 | 16 | 36931259 |
| Pubmed | TCF3 IL15RA TCF12 ZNF207 TSEN54 EYA3 UBN2 RXRB NCOR2 SALL2 NFATC1 TMPO KMT2A BSN JPT2 MTUS2 PRRC2B | 1.42e-08 | 1006 | 108 | 17 | 15226823 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | IRF2BP2 TCF12 ZNF207 EYA3 MED1 BCOR UBN2 NCOR2 EPS15L1 ARNT SALL2 TMPO | 1.49e-08 | 444 | 108 | 12 | 34795231 |
| Pubmed | Enhancer activation requires trans-recruitment of a mega transcription factor complex. | 1.82e-08 | 10 | 108 | 4 | 25303530 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | IRF2BP2 DSP CKAP5 PUM2 MED1 BCOR NCOR2 EPS15L1 YLPM1 TMPO KMT2A KAT6B KLHDC4 MED13 TP53BP1 | 1.83e-08 | 774 | 108 | 15 | 15302935 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | IRF2BP2 PUM2 ZNF207 BCOR ANKHD1 NCOR2 ARNT YLPM1 SEC23IP TMPO MAML3 PRRC2B | 2.05e-08 | 457 | 108 | 12 | 32344865 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXO3 ATF7 TSHZ3 TCF3 TCF12 RUNX2 FOXI3 RXRA RXRB TFE3 OTP ARNT SALL2 NFATC1 KMT2A TCF7L1 | 2.21e-08 | 908 | 108 | 16 | 19274049 |
| Pubmed | 2.69e-08 | 152 | 108 | 8 | 38360978 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 ATF7 TCF3 CDC42BPA BCAS3 AFF3 ARHGEF18 PARD3B SSBP3 UBN2 RXRA KIAA1671 DOCK5 NCOR2 EPS15L1 PTPN13 NFATC1 TNK2 KAT6B MAML3 | 3.03e-08 | 1489 | 108 | 20 | 28611215 |
| Pubmed | CBLL1 CDC42BPA NACA CKAP5 PUM2 ZNF207 KAT2A MED1 BCOR SSBP3 ANKHD1 UBN2 INO80D KIAA1671 PTPN13 ARID2 PXN KMT2A MED12 MED13 | 3.31e-08 | 1497 | 108 | 20 | 31527615 | |
| Pubmed | Control of developmentally primed erythroid genes by combinatorial co-repressor actions. | 3.52e-08 | 30 | 108 | 5 | 26593974 | |
| Pubmed | CBLL1 CTTNBP2 CKAP5 ARHGEF18 SEC31A BCOR UBN2 DNAJC6 NCOR2 EPS15L1 YLPM1 SEC23IP RIMBP2 BSN TP53BP1 PRRC2B | 4.97e-08 | 963 | 108 | 16 | 28671696 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | TCF12 CDC42BPA CKAP5 PUM2 SALL4 MED1 NCOR2 SALL2 YLPM1 TMPO KMT2A | 6.79e-08 | 411 | 108 | 11 | 35182466 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXO3 ATF7 ASXL1 TCF12 DSP BCAS3 CKAP5 ANKHD1 RXRA RXRB NCOR2 ARNT SALL2 NFATC1 TP53BP1 | 6.93e-08 | 857 | 108 | 15 | 25609649 |
| Pubmed | 8.59e-08 | 14 | 108 | 4 | 20854876 | ||
| Pubmed | 1.17e-07 | 15 | 108 | 4 | 18418385 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | TSHZ3 BCOR UBN2 KIAA1671 NCOR2 ARNT ARID2 KMT2A MED12 PRRC2B | 1.56e-07 | 351 | 108 | 10 | 38297188 |
| Pubmed | 1.68e-07 | 268 | 108 | 9 | 33640491 | ||
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 3.29e-07 | 19 | 108 | 4 | 16799563 | |
| Pubmed | STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. | 4.10e-07 | 20 | 108 | 4 | 17967894 | |
| Pubmed | 4.10e-07 | 20 | 108 | 4 | 15340084 | ||
| Pubmed | CCP110 STIM2 CTTNBP2 KIAA0586 ARHGEF18 UBN2 VPS13D PER3 ARID2 MAML3 MED12 | 4.16e-07 | 493 | 108 | 11 | 15368895 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CBLL1 ATF7 TCF3 DSP CKAP5 KAT2A MED1 BCOR UBN2 INO80D TFE3 DOCK5 NCOR2 ARNT YLPM1 TMPO KMT2A | 5.09e-07 | 1294 | 108 | 17 | 30804502 |
| Pubmed | STIM2 LYPLAL1 NACA PUM2 ZNF207 SEC31A EYA3 KIAA1671 EPS15L1 PTPN13 SALL2 SEC23IP PXN TMPO PRRC2B | 5.41e-07 | 1007 | 108 | 15 | 34597346 | |
| Pubmed | 8.24e-07 | 102 | 108 | 6 | 19741146 | ||
| Pubmed | 8.91e-07 | 24 | 108 | 4 | 33722704 | ||
| Pubmed | STIM2 TCF12 CDC42BPA MUC16 SEC31A KIAA1671 DOCK5 EPS15L1 PTPN13 SEC23IP TMPO PRRC1 PRRC2B | 9.17e-07 | 777 | 108 | 13 | 35844135 | |
| Pubmed | 9.77e-07 | 105 | 108 | 6 | 9628581 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TSHZ3 ARHGEF18 KIAA1671 DOCK5 NCOR2 ARID2 YLPM1 TNK2 BSN PRRC1 | 9.91e-07 | 430 | 108 | 10 | 35044719 |
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 1.61e-06 | 8 | 108 | 3 | 32179550 | |
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 19786558 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.84e-06 | 184 | 108 | 7 | 32908313 | |
| Pubmed | CTTNBP2 DSP BCAS3 PCLO CKAP5 DNAJC6 ADD2 EPS15L1 PTPRZ1 TMPO KMT2A RIMBP2 DMD BSN MTUS2 CNTN2 PRRC2B | 2.01e-06 | 1431 | 108 | 17 | 37142655 | |
| Pubmed | Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. | 2.41e-06 | 9 | 108 | 3 | 8710870 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | BCAS3 CKAP5 PUM2 SEC31A MED1 ANKHD1 UBN2 PTPN13 YLPM1 PXN JPT2 PRRC2B | 2.73e-06 | 724 | 108 | 12 | 36232890 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.41e-06 | 202 | 108 | 7 | 33005030 | |
| Pubmed | A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. | 3.44e-06 | 10 | 108 | 3 | 12218053 | |
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 3.44e-06 | 10 | 108 | 3 | 30595551 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.53e-06 | 203 | 108 | 7 | 22083510 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 4.23e-06 | 135 | 108 | 6 | 31077711 | |
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 4.72e-06 | 11 | 108 | 3 | 15681609 | |
| Pubmed | Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. | 4.72e-06 | 11 | 108 | 3 | 12037571 | |
| Pubmed | IRF2BP2 MUC16 MED1 BCOR TFE3 NCOR2 ARID2 SEC23IP BSN MAML3 PRRC2B | 5.02e-06 | 638 | 108 | 11 | 31182584 | |
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 28700933 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 23563140 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 26427057 | ||
| Pubmed | 6.65e-06 | 39 | 108 | 4 | 38690566 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 6.98e-06 | 536 | 108 | 10 | 15840001 | |
| Pubmed | 7.21e-06 | 538 | 108 | 10 | 10512203 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 7.63e-06 | 321 | 108 | 8 | 32098917 | |
| Pubmed | A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. | 8.14e-06 | 13 | 108 | 3 | 14657022 | |
| Pubmed | CDK8 is a positive regulator of transcriptional elongation within the serum response network. | 8.14e-06 | 13 | 108 | 3 | 20098423 | |
| Pubmed | 8.14e-06 | 13 | 108 | 3 | 27570068 | ||
| Pubmed | Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. | 8.14e-06 | 13 | 108 | 3 | 19255064 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 8.22e-06 | 231 | 108 | 7 | 16452087 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CBLL1 DSP ZNF207 MED1 BCOR UBN2 NCOR2 EPS15L1 ARID2 YLPM1 TMPO KMT2A TP53BP1 | 8.55e-06 | 954 | 108 | 13 | 36373674 |
| Pubmed | Downregulation of E Protein Activity Augments an ILC2 Differentiation Program in the Thymus. | 9.55e-06 | 2 | 108 | 2 | 28258196 | |
| Pubmed | RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. | 9.55e-06 | 2 | 108 | 2 | 7926783 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21730189 | ||
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 9.55e-06 | 2 | 108 | 2 | 23403927 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18093538 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 38892207 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10958665 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20154672 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 9.55e-06 | 2 | 108 | 2 | 26793095 | |
| Pubmed | E2A promotes the survival of precursor and mature B lymphocytes. | 9.55e-06 | 2 | 108 | 2 | 16888011 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20332206 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24810760 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16105548 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8780715 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21383990 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22316320 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 9.55e-06 | 2 | 108 | 2 | 21935939 | |
| Pubmed | E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression. | 9.55e-06 | 2 | 108 | 2 | 17442955 | |
| Pubmed | MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. | 9.55e-06 | 2 | 108 | 2 | 21741597 | |
| Pubmed | DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy. | 9.55e-06 | 2 | 108 | 2 | 24858818 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 33246082 | ||
| Pubmed | Endogenous retinoid X receptor ligands in mouse hematopoietic cells. | 9.55e-06 | 2 | 108 | 2 | 29089448 | |
| Pubmed | RUNX2 and IL-15RA Polymorphisms associated with OPLL in the Han and Mongolian population. | 9.55e-06 | 2 | 108 | 2 | 33177736 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20398753 | ||
| Pubmed | Paxillin phosphorylation by JNK and p38 is required for NFAT activation. | 9.55e-06 | 2 | 108 | 2 | 22865050 | |
| Pubmed | Correlation between circulating innate lymphoid cell precursors and thymic function. | 9.55e-06 | 2 | 108 | 2 | 35118353 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16199515 | ||
| Pubmed | The role of DOT1L in the maintenance of leukemia gene expression. | 9.55e-06 | 2 | 108 | 2 | 27151433 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 38839978 | ||
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 9.55e-06 | 2 | 108 | 2 | 25652077 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12743608 | ||
| Pubmed | LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia. | 9.55e-06 | 2 | 108 | 2 | 12203795 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20798333 | ||
| Interaction | TLE3 interactions | CBLL1 IRF2BP2 TSHZ3 TCF3 TCF12 CECR2 ZNF207 EYA3 BCOR UBN2 INO80D NCOR2 ARNT ARID2 KMT2A DOT1L | 1.68e-10 | 376 | 108 | 16 | int:TLE3 |
| Interaction | SOX2 interactions | IRF2BP2 TSHZ3 TCF3 TCF12 CDC42BPA DSP CKAP5 PUM2 SALL4 RUNX2 MED1 BCOR SSBP3 ANKHD1 UBN2 TFE3 KIAA1671 NCOR2 ARNT SALL2 ARID2 YLPM1 TMPO KMT2A KAT6B PRRC1 PRRC2B | 5.07e-09 | 1422 | 108 | 27 | int:SOX2 |
| Interaction | BAG2 interactions | IRF2BP2 ASXL1 C3orf38 CKAP5 EYA3 BCOR ANKHD1 UBN2 DNAJC6 KIAA1671 DOCK5 VPS13D ARNT SALL2 PXN DOT1L MED12 | 3.41e-08 | 622 | 108 | 17 | int:BAG2 |
| Interaction | CTBP1 interactions | FOXO3 TSHZ3 TCF3 BCAS3 PCLO SEC31A KAT2A MED1 BCOR NCOR2 NFATC1 SEC23IP KMT2A PRRC2B | 3.63e-08 | 406 | 108 | 14 | int:CTBP1 |
| Interaction | NANOG interactions | CECR2 MUC16 PUM2 SALL4 BCOR SSBP3 TFE3 NCOR2 ARNT SALL2 DOT1L TCF7L1 MED12 TP53BP1 | 2.90e-07 | 481 | 108 | 14 | int:NANOG |
| Interaction | WWTR1 interactions | RUNX2 BCOR ANKHD1 KIAA1671 EPS15L1 ARNT PTPN13 NFATC1 ARID2 SEC23IP KMT2A TP53BP1 PRRC2B | 4.21e-07 | 422 | 108 | 13 | int:WWTR1 |
| Interaction | CEBPA interactions | ATF7 IRF2BP2 ASXL1 TCF3 TCF12 CKAP5 ZNF207 KAT2A EYA3 RUNX2 MED1 BCOR UBN2 INO80D NCOR2 ARNT ARID2 TMPO KMT2A MED12 TP53BP1 PRRC2B | 6.05e-07 | 1245 | 108 | 22 | int:CEBPA |
| Interaction | SP7 interactions | IRF2BP2 TSHZ3 KAT2A EYA3 BCOR SSBP3 NCOR2 ARNT ARID2 YLPM1 PRRC2B | 7.23e-07 | 304 | 108 | 11 | int:SP7 |
| Interaction | NAA40 interactions | IRF2BP2 DSP NACA CKAP5 PUM2 MED1 BCOR ANKHD1 KIAA1671 EPS15L1 PTPN13 ARID2 YLPM1 SEC23IP TMPO KMT2A JPT2 TP53BP1 PRRC2B | 9.95e-07 | 978 | 108 | 19 | int:NAA40 |
| Interaction | AR interactions | IRF2BP2 ASXL1 CDC42BPA DSP RUNX2 MED1 BCOR UBN2 NCOR2 ARNT ARID2 YLPM1 PXN KMT2A TNK2 DOT1L MED12 MED13 PRRC2B | 1.23e-06 | 992 | 108 | 19 | int:AR |
| Interaction | GATA2 interactions | 1.25e-06 | 199 | 108 | 9 | int:GATA2 | |
| Interaction | YWHAH interactions | FOXO3 CCP110 STIM2 CDC42BPA DSP BCAS3 CKAP5 PARD3B PLEKHG2 MED1 TFE3 KIAA1671 ZCCHC14 VPS13D PTPN13 GRID2IP MS4A1 MAP3K9 KMT2A PRRC1 | 1.42e-06 | 1102 | 108 | 20 | int:YWHAH |
| Interaction | HDAC1 interactions | TSHZ3 CDC42BPA BCAS3 CKAP5 SALL4 RUNX2 BCOR ANKHD1 DNAJC6 TFE3 KIAA1671 NCOR2 ARNT PTPN13 NFATC1 SEC23IP PXN KMT2A DOT1L MED12 | 1.55e-06 | 1108 | 108 | 20 | int:HDAC1 |
| Interaction | POU5F1 interactions | NACA CKAP5 ZBTB47 MUC16 SALL4 UBN2 TFE3 NCOR2 SALL2 TMPO TCF7L1 PRRC1 TP53BP1 PRRC2B | 2.88e-06 | 584 | 108 | 14 | int:POU5F1 |
| Interaction | NUP35 interactions | IRF2BP2 PUM2 ZNF207 BCOR ANKHD1 NCOR2 ARNT YLPM1 SEC23IP TMPO MAML3 PRRC2B | 2.90e-06 | 424 | 108 | 12 | int:NUP35 |
| Interaction | KLF3 interactions | 3.84e-06 | 228 | 108 | 9 | int:KLF3 | |
| Interaction | EGR2 interactions | 3.90e-06 | 171 | 108 | 8 | int:EGR2 | |
| Interaction | TRRAP interactions | FOXO3 IRF2BP2 TCF3 DSP NACA KAT2A MED1 RNF17 DOCK5 NCOR2 ARNT NFATC1 DMD DOT1L MED12 MED13 | 4.68e-06 | 790 | 108 | 16 | int:TRRAP |
| Interaction | TEAD1 interactions | 4.83e-06 | 176 | 108 | 8 | int:TEAD1 | |
| Interaction | VDR interactions | 5.50e-06 | 127 | 108 | 7 | int:VDR | |
| Interaction | NR1I3 interactions | 5.74e-06 | 48 | 108 | 5 | int:NR1I3 | |
| Interaction | IRF4 interactions | 6.39e-06 | 85 | 108 | 6 | int:IRF4 | |
| Interaction | MED15 interactions | 6.75e-06 | 131 | 108 | 7 | int:MED15 | |
| Interaction | ASF1A interactions | 7.84e-06 | 249 | 108 | 9 | int:ASF1A | |
| Interaction | SMG7 interactions | 8.44e-06 | 319 | 108 | 10 | int:SMG7 | |
| Interaction | PML interactions | IRF2BP2 TCF12 ZNF207 EYA3 RUNX2 MED1 BCOR UBN2 RXRA NCOR2 EPS15L1 ARNT NFATC1 PXN TMPO KMT2A TP53BP1 | 9.27e-06 | 933 | 108 | 17 | int:PML |
| Interaction | MYOD1 interactions | 9.88e-06 | 194 | 108 | 8 | int:MYOD1 | |
| Interaction | C6orf141 interactions | 1.01e-05 | 92 | 108 | 6 | int:C6orf141 | |
| Interaction | MED25 interactions | 1.08e-05 | 93 | 108 | 6 | int:MED25 | |
| Interaction | RCOR1 interactions | TSHZ3 TCF3 DSP CKAP5 BCOR ANKHD1 DNAJC6 NCOR2 PTPN13 SALL2 MED12 TP53BP1 | 1.36e-05 | 494 | 108 | 12 | int:RCOR1 |
| Interaction | FEV interactions | 1.37e-05 | 203 | 108 | 8 | int:FEV | |
| Interaction | DPY30 interactions | 1.42e-05 | 204 | 108 | 8 | int:DPY30 | |
| Interaction | PHF21A interactions | TSHZ3 DSP CKAP5 BCOR ANKHD1 KIAA1671 PTPN13 SALL2 SEC23IP PXN | 1.58e-05 | 343 | 108 | 10 | int:PHF21A |
| Interaction | HNF4A interactions | 1.73e-05 | 275 | 108 | 9 | int:HNF4A | |
| Interaction | SUPT3H interactions | 1.89e-05 | 61 | 108 | 5 | int:SUPT3H | |
| Interaction | SOX6 interactions | 2.20e-05 | 157 | 108 | 7 | int:SOX6 | |
| Interaction | IRF2BP2 interactions | 2.81e-05 | 110 | 108 | 6 | int:IRF2BP2 | |
| Interaction | NR1H2 interactions | 3.21e-05 | 68 | 108 | 5 | int:NR1H2 | |
| Interaction | YWHAG interactions | FOXO3 CCP110 STIM2 CDC42BPA DSP BCAS3 CKAP5 PARD3B PLEKHG2 TFE3 KIAA1671 VPS13D PTPN13 GRID2IP MS4A1 MAP3K9 KMT2A TNK2 PRRC1 | 3.27e-05 | 1248 | 108 | 19 | int:YWHAG |
| Interaction | KDM1A interactions | TSHZ3 TCF3 DSP CKAP5 BCOR ANKHD1 DNAJC6 KIAA1671 NCOR2 PTPN13 SALL2 SEC23IP PXN KLHDC4 MED12 TP53BP1 | 4.04e-05 | 941 | 108 | 16 | int:KDM1A |
| Interaction | TCF15 interactions | 4.12e-05 | 13 | 108 | 3 | int:TCF15 | |
| Interaction | MED16 interactions | 4.59e-05 | 120 | 108 | 6 | int:MED16 | |
| Interaction | FOS interactions | 4.65e-05 | 312 | 108 | 9 | int:FOS | |
| Interaction | EYA4 interactions | 4.97e-05 | 243 | 108 | 8 | int:EYA4 | |
| Interaction | GUSBP5 interactions | 5.16e-05 | 75 | 108 | 5 | int:GUSBP5 | |
| Interaction | MED20 interactions | 5.46e-05 | 181 | 108 | 7 | int:MED20 | |
| Interaction | RUNX1 interactions | 6.23e-05 | 324 | 108 | 9 | int:RUNX1 | |
| Interaction | CBFA2T3 interactions | 6.23e-05 | 78 | 108 | 5 | int:CBFA2T3 | |
| Interaction | FXR1 interactions | CECR2 BCOR ANKHD1 KIAA1671 NCOR2 EPS15L1 NFATC1 TMPO DOT1L KIF17 MTUS2 TP53BP1 PRRC2B | 7.00e-05 | 679 | 108 | 13 | int:FXR1 |
| Interaction | PPARGC1A interactions | 7.92e-05 | 82 | 108 | 5 | int:PPARGC1A | |
| Interaction | SOX7 interactions | 7.92e-05 | 82 | 108 | 5 | int:SOX7 | |
| Interaction | PTF1A interactions | 7.97e-05 | 16 | 108 | 3 | int:PTF1A | |
| Interaction | CREBBP interactions | FOXO3 TCF3 TCF12 KAT2A RUNX2 RXRA NCOR2 ARNT NFATC1 KMT2A CNTN2 TP53BP1 | 8.84e-05 | 599 | 108 | 12 | int:CREBBP |
| Interaction | YWHAQ interactions | CBLL1 FOXO3 CCP110 TCF3 CDC42BPA PARD3B MED1 TFE3 KIAA1671 VPS13D PTPN13 MS4A1 NFATC1 MAP3K9 TMPO KMT2A PCK1 | 9.10e-05 | 1118 | 108 | 17 | int:YWHAQ |
| Interaction | TOP3B interactions | FOXO3 CDC42BPA BCAS3 NTSR1 KAT2A ANKHD1 TFE3 CCDC142 ZCCHC14 NCOR2 EPS15L1 NFATC1 ADAMTS7 PXN TNK2 DOT1L MED12 MED13 TP53BP1 PRRC2B | 9.52e-05 | 1470 | 108 | 20 | int:TOP3B |
| Interaction | TADA3 interactions | 1.12e-04 | 141 | 108 | 6 | int:TADA3 | |
| Interaction | LRRC31 interactions | 1.19e-04 | 205 | 108 | 7 | int:LRRC31 | |
| Interaction | EP300 interactions | FOXO3 TCF3 TCF12 NACA SEC31A KAT2A RUNX2 MED1 RXRA NCOR2 ARNT NFATC1 YLPM1 TMPO TNK2 BSN PCK1 CNTN2 TP53BP1 | 1.52e-04 | 1401 | 108 | 19 | int:EP300 |
| Interaction | ZBTB7B interactions | 1.57e-04 | 366 | 108 | 9 | int:ZBTB7B | |
| Interaction | SNRNP40 interactions | CBLL1 TCF12 ZNF207 EYA3 BCOR UBN2 NCOR2 ARNT ARID2 KMT2A DOT1L MED12 | 1.57e-04 | 637 | 108 | 12 | int:SNRNP40 |
| Interaction | TBX5 interactions | 1.58e-04 | 150 | 108 | 6 | int:TBX5 | |
| Interaction | SMARCE1 interactions | 1.58e-04 | 287 | 108 | 8 | int:SMARCE1 | |
| Interaction | EGLN3 interactions | FOXO3 CCP110 TCF3 STIM2 TCF12 KIAA0586 CKAP5 EYA3 BCOR ANKHD1 KIAA1671 ZCCHC14 NCOR2 ARNT PTPN13 NFATC1 TMPO PRRC2B | 1.73e-04 | 1296 | 108 | 18 | int:EGLN3 |
| Interaction | VRTN interactions | 1.86e-04 | 21 | 108 | 3 | int:VRTN | |
| Interaction | YWHAZ interactions | FOXO3 CCP110 ASXL1 STIM2 CDC42BPA CKAP5 ARHGEF18 PARD3B BCOR TFE3 KIAA1671 VPS13D PTPN13 MS4A1 MAP3K9 KMT2A TNK2 TP53BP1 | 2.16e-04 | 1319 | 108 | 18 | int:YWHAZ |
| Interaction | SALL1 interactions | 2.22e-04 | 102 | 108 | 5 | int:SALL1 | |
| Interaction | KCNA3 interactions | STIM2 CDC42BPA DSP NACA CKAP5 SEC31A ADD2 EPS15L1 PTPN13 SEC23IP TMPO KMT2A BSN MED12 | 2.29e-04 | 871 | 108 | 14 | int:KCNA3 |
| Interaction | SLX4 interactions | IRF2BP2 TCF12 DSP NACA AFF3 BCOR ANKHD1 UBN2 SALL2 TP53BP1 PRRC2B | 2.51e-04 | 572 | 108 | 11 | int:SLX4 |
| Interaction | HAND1 interactions | 2.79e-04 | 24 | 108 | 3 | int:HAND1 | |
| Interaction | NCAPH2 interactions | 3.01e-04 | 169 | 108 | 6 | int:NCAPH2 | |
| Interaction | SCAI interactions | 3.02e-04 | 60 | 108 | 4 | int:SCAI | |
| Interaction | CTNNB1 interactions | FOXO3 TCF3 PARD3B KAT2A RUNX2 RXRA KIAA1671 ARNT PTPN13 PTPRZ1 PXN TMPO KMT2A DOT1L TCF7L1 | 3.13e-04 | 1009 | 108 | 15 | int:CTNNB1 |
| Interaction | THRA interactions | 3.29e-04 | 111 | 108 | 5 | int:THRA | |
| Interaction | TLX1 interactions | 3.62e-04 | 175 | 108 | 6 | int:TLX1 | |
| Interaction | CDC16 interactions | 3.63e-04 | 246 | 108 | 7 | int:CDC16 | |
| Interaction | CARM1 interactions | 3.65e-04 | 325 | 108 | 8 | int:CARM1 | |
| Interaction | GATA4 interactions | 3.69e-04 | 411 | 108 | 9 | int:GATA4 | |
| Interaction | NR4A2 interactions | 3.99e-04 | 27 | 108 | 3 | int:NR4A2 | |
| Interaction | PDLIM4 interactions | 3.99e-04 | 27 | 108 | 3 | int:PDLIM4 | |
| Interaction | TBXT interactions | 4.03e-04 | 116 | 108 | 5 | int:TBXT | |
| Interaction | KAT2A interactions | 4.21e-04 | 180 | 108 | 6 | int:KAT2A | |
| Interaction | HMGA1 interactions | 4.25e-04 | 419 | 108 | 9 | int:HMGA1 | |
| Interaction | TSC22D2 interactions | 4.35e-04 | 66 | 108 | 4 | int:TSC22D2 | |
| Interaction | CRX interactions | 4.40e-04 | 254 | 108 | 7 | int:CRX | |
| Interaction | ELK3 interactions | 4.71e-04 | 120 | 108 | 5 | int:ELK3 | |
| Interaction | LHX3 interactions | 4.87e-04 | 185 | 108 | 6 | int:LHX3 | |
| Interaction | MED8 interactions | 4.89e-04 | 121 | 108 | 5 | int:MED8 | |
| Interaction | FASN interactions | CBLL1 ASXL1 DSP MED1 ZCCHC14 ARNT ARID2 YLPM1 TMPO KMT2A DOT1L MED12 PCK1 MED13 TP53BP1 | 5.35e-04 | 1062 | 108 | 15 | int:FASN |
| Interaction | PAX7 interactions | 5.47e-04 | 124 | 108 | 5 | int:PAX7 | |
| Interaction | HNF1B interactions | 5.60e-04 | 190 | 108 | 6 | int:HNF1B | |
| Interaction | QKI interactions | 5.60e-04 | 190 | 108 | 6 | int:QKI | |
| Interaction | MED13L interactions | 5.75e-04 | 71 | 108 | 4 | int:MED13L | |
| Interaction | FMR1 interactions | CBLL1 CECR2 CKAP5 PUM2 ARHGEF18 NCOR2 DOT1L BSN TP53BP1 PRRC2B | 6.13e-04 | 536 | 108 | 10 | int:FMR1 |
| Interaction | SMARCC2 interactions | 6.30e-04 | 353 | 108 | 8 | int:SMARCC2 | |
| Interaction | KLF5 interactions | 6.42e-04 | 195 | 108 | 6 | int:KLF5 | |
| Interaction | NR1H4 interactions | 6.63e-04 | 32 | 108 | 3 | int:NR1H4 | |
| Interaction | PHIP interactions | 6.77e-04 | 197 | 108 | 6 | int:PHIP | |
| Interaction | H3-3A interactions | TSHZ3 CKAP5 KAT2A EYA3 MED1 BCOR UBN2 TFE3 ARID2 TMPO KMT2A DOT1L | 6.78e-04 | 749 | 108 | 12 | int:H3-3A |
| Interaction | TADA2A interactions | 6.95e-04 | 198 | 108 | 6 | int:TADA2A | |
| Interaction | NR3C1 interactions | IRF2BP2 DSP MUC16 MED1 BCOR RXRB TFE3 NCOR2 NFATC1 ARID2 SEC23IP BSN MAML3 PRRC2B | 7.01e-04 | 974 | 108 | 14 | int:NR3C1 |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.31e-04 | 25 | 72 | 3 | 775 | |
| GeneFamily | Cyclins|Mediator complex | 3.03e-04 | 33 | 72 | 3 | 1061 | |
| GeneFamily | Basic helix-loop-helix proteins | 9.71e-04 | 110 | 72 | 4 | 420 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.59e-03 | 15 | 72 | 2 | 26 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.05e-03 | 17 | 72 | 2 | 486 | |
| GeneFamily | PDZ domain containing | 3.17e-03 | 152 | 72 | 4 | 1220 | |
| Coexpression | GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP | 1.28e-05 | 187 | 108 | 7 | M3287 | |
| Coexpression | CYCLIN_D1_KE_.V1_DN | 1.46e-05 | 191 | 108 | 7 | M2647 | |
| Coexpression | GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 1.85e-05 | 198 | 108 | 7 | M4462 | |
| Coexpression | MARTIN_INTERACT_WITH_HDAC | 2.45e-05 | 41 | 108 | 4 | M15154 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | CBLL1 IRF2BP2 CTTNBP2 DSP PUM2 PEX13 SALL4 RUNX2 DNAJC6 NFATC1 PTPRZ1 YLPM1 TMPO KAT6B MED13 | 1.93e-05 | 836 | 107 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-07 | 188 | 108 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.51e-07 | 198 | 108 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.70e-07 | 199 | 108 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 3.71e-06 | 170 | 108 | 6 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 174 | 108 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 6.40e-06 | 187 | 108 | 6 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | Healthy_donor-B_memory|Healthy_donor / disease group, cell group and cell class (v2) | 7.01e-06 | 190 | 108 | 6 | 46104a521f00d399315deca86699cb261b2795d6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 7.45e-06 | 192 | 108 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 194 | 108 | 6 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 8.38e-06 | 196 | 108 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.38e-06 | 196 | 108 | 6 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.62e-06 | 197 | 108 | 6 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.13e-06 | 199 | 108 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.93e-05 | 156 | 108 | 5 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.93e-05 | 156 | 108 | 5 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.05e-05 | 157 | 108 | 5 | 6730b775308f45a2f3946016bdbb7f8e5b5efe49 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 160 | 108 | 5 | 237430af14830b38e58da8a4224036e5c6b71c5b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.28e-05 | 166 | 108 | 5 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.28e-05 | 166 | 108 | 5 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.28e-05 | 166 | 108 | 5 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 168 | 108 | 5 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.08e-05 | 171 | 108 | 5 | eddc5e05003382603ee49f74b9e2242a43021096 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 174 | 108 | 5 | b2fc2a756f8e373ad903bd416d9de703d945fa1c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-05 | 175 | 108 | 5 | c031da47ca63d1133e13530cbf779df9435e22cb | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.15e-05 | 177 | 108 | 5 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.15e-05 | 177 | 108 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.15e-05 | 177 | 108 | 5 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 178 | 108 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 7.74e-05 | 180 | 108 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.95e-05 | 181 | 108 | 5 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.95e-05 | 181 | 108 | 5 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.95e-05 | 181 | 108 | 5 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-05 | 184 | 108 | 5 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 8.59e-05 | 184 | 108 | 5 | 2817d530863e85dfdcd143b7a3dc5fc58a9cd98b | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.27e-05 | 187 | 108 | 5 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.50e-05 | 188 | 108 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.50e-05 | 188 | 108 | 5 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 9.50e-05 | 188 | 108 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.50e-05 | 188 | 108 | 5 | cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 9.74e-05 | 189 | 108 | 5 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-05 | 189 | 108 | 5 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 9.99e-05 | 190 | 108 | 5 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 9.99e-05 | 190 | 108 | 5 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-05 | 190 | 108 | 5 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-04 | 192 | 108 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-04 | 192 | 108 | 5 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-04 | 193 | 108 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-04 | 193 | 108 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | mild_COVID-19-B_memory|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.07e-04 | 193 | 108 | 5 | 7e6fe70928a50b0a8f12220e572c07c5670d092e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.07e-04 | 193 | 108 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Marrow-B-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 193 | 108 | 5 | 24c34c6635eb7fc2878282803c421b64320e77d8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.07e-04 | 193 | 108 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-04 | 193 | 108 | 5 | de0213f2105b814f38ffbfd004ea7603230eed68 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.07e-04 | 193 | 108 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-04 | 193 | 108 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 1.07e-04 | 193 | 108 | 5 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 194 | 108 | 5 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 194 | 108 | 5 | 7ee8ac172c2dee7df7dc4eb222e0985a0089bda8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-04 | 195 | 108 | 5 | 0c49d22c348aec6d8a1a976e7c88d0a3b48a4244 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 195 | 108 | 5 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-04 | 196 | 108 | 5 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.16e-04 | 196 | 108 | 5 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 196 | 108 | 5 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.18e-04 | 197 | 108 | 5 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 1.18e-04 | 197 | 108 | 5 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | 15-Distal-Epithelial-Bud_tip_progenitor|Distal / Age, Tissue, Lineage and Cell class | 1.18e-04 | 197 | 108 | 5 | 532635810f17199fa6c14b986f663884d5d05ab5 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 197 | 108 | 5 | 6852a8ec1397811bbdd1fc625c52ed4fa75a931e | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.18e-04 | 197 | 108 | 5 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.18e-04 | 197 | 108 | 5 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.21e-04 | 198 | 108 | 5 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.21e-04 | 198 | 108 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 199 | 108 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | ILEUM-inflamed-(6)_ILC-(6)_ILC3|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.24e-04 | 199 | 108 | 5 | 02879df850b0c72b57d7b22cfc43f3407e182dcb | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_memory|COVID-19_Mild / Disease, condition lineage and cell class | 1.24e-04 | 199 | 108 | 5 | 54e392b4ebe601d4838739ff7de3ac6b2203c948 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.27e-04 | 200 | 108 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 110 | 108 | 4 | bc1986e5a496a4d25da3445b6f252f81741619f4 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.36e-04 | 124 | 108 | 4 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.74e-04 | 129 | 108 | 4 | 7d537680b0dfb764f7914d0475c66b678b5cb8d2 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-04 | 131 | 108 | 4 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.26e-04 | 135 | 108 | 4 | 0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-3|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 3.36e-04 | 136 | 108 | 4 | 4f5e0b6c7d6e3e922af4daa7c3eb56490455c1df | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-04 | 138 | 108 | 4 | 76be06136c83c167cedece7515228ed4d29dd1f0 | |
| ToppCell | Severe-B_naive-9|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.65e-04 | 139 | 108 | 4 | b9b049953958f15d773eb5cca6d5dc34f4829543 | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.85e-04 | 141 | 108 | 4 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | COVID-19_Moderate-B_cell|COVID-19_Moderate / disease group, cell group and cell class | 3.95e-04 | 142 | 108 | 4 | 88bb8d9bca66131df4ee7021b88248e146aa7aa6 | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.28e-04 | 145 | 108 | 4 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|ILC / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-04 | 61 | 108 | 3 | d0b33a48ee2faf68b270f9279c630437f3e8b20b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-04 | 147 | 108 | 4 | c8e5bdc3538089acd35a4b41390afaec0ac6d1aa | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-04 | 152 | 108 | 4 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 10uM; PC3; HT_HG-U133A | 4.58e-06 | 197 | 108 | 8 | 4559_UP | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.58e-06 | 197 | 108 | 8 | 6815_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 4.75e-06 | 198 | 108 | 8 | 6991_DN | |
| Drug | 17-AAG; Down 200; 0.1uM; MCF7; HG-U133A | 4.75e-06 | 198 | 108 | 8 | 221_DN | |
| Drug | AC1L3UEY | 1.66e-05 | 113 | 108 | 6 | CID000122342 | |
| Drug | NSC-364372 | FOXO3 NACA RUNX2 RXRA EPS15L1 ARNT PER3 NFATC1 KIF17 JPT2 MED12 | 1.93e-05 | 484 | 108 | 11 | CID000435143 |
| Drug | Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.21e-05 | 196 | 108 | 7 | 7024_DN | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; HL60; HT_HG-U133A | 4.21e-05 | 196 | 108 | 7 | 6130_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; HL60; HG-U133A | 4.21e-05 | 196 | 108 | 7 | 1379_UP | |
| Drug | Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 3230_DN | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 108 | 7 | 3616_UP | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 6256_DN | |
| Drug | novobiocin sodium, USP; Up 200; 100uM; SKMEL5; HG-U133A | 4.49e-05 | 198 | 108 | 7 | 632_UP | |
| Drug | HA-1077 dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 4.49e-05 | 198 | 108 | 7 | 343_UP | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A | 4.49e-05 | 198 | 108 | 7 | 4333_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A | 4.49e-05 | 198 | 108 | 7 | 347_DN | |
| Drug | F-L-Leu | 4.73e-05 | 83 | 108 | 5 | CID000004308 | |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.79e-05 | 200 | 108 | 7 | 6484_DN | |
| Drug | vitamin D3 | 5.34e-05 | 277 | 108 | 8 | CID000002735 | |
| Drug | 9-HODE | 6.01e-05 | 142 | 108 | 6 | CID000001927 | |
| Drug | Bexarotene | 6.67e-05 | 3 | 108 | 2 | DB00307 | |
| Drug | 2-hydroxyphytanic acid | 6.67e-05 | 3 | 108 | 2 | ctd:C002585 | |
| Drug | AC1O5SBP | 6.67e-05 | 3 | 108 | 2 | CID006439746 | |
| Drug | phthalic acid | 6.72e-05 | 17 | 108 | 3 | ctd:C032279 | |
| Disease | FEV/FEC ratio | FOXO3 ASXL1 TSHZ3 CTTNBP2 DSP LYPLAL1 BCAS3 KIAA0586 AFF3 ARHGEF18 TSEN54 RUNX2 TFE3 NFATC1 YLPM1 TCF7L1 CNTN2 | 1.78e-06 | 1228 | 106 | 17 | EFO_0004713 |
| Disease | obesity (implicated_via_orthology) | 1.31e-05 | 215 | 106 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | intraocular pressure measurement | 1.55e-05 | 509 | 106 | 10 | EFO_0004695 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.94e-05 | 49 | 106 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Pitt-Hopkins syndrome (implicated_via_orthology) | 3.83e-05 | 3 | 106 | 2 | DOID:0060488 (implicated_via_orthology) | |
| Disease | testosterone measurement | IRF2BP2 TCF12 C3orf38 CECR2 RXRA CRYBA1 DOCK5 NCOR2 ARNT PER3 NFATC1 SEC23IP RIMBP2 JPT2 MED12 | 5.10e-05 | 1275 | 106 | 15 | EFO_0004908 |
| Disease | unipolar depression, depressive symptom measurement | 1.10e-04 | 26 | 106 | 3 | EFO_0003761, EFO_0007006 | |
| Disease | eye measurement | 1.24e-04 | 27 | 106 | 3 | EFO_0004731 | |
| Disease | chronic obstructive pulmonary disease | TSHZ3 DSP LYPLAL1 BCAS3 AFF3 TSEN54 RUNX2 DOT1L TCF7L1 MAML3 | 1.90e-04 | 688 | 106 | 10 | EFO_0000341 |
| Disease | smoking status measurement, high density lipoprotein cholesterol measurement | 2.65e-04 | 7 | 106 | 2 | EFO_0004612, EFO_0006527 | |
| Disease | chronic kidney disease, diabetic nephropathy | 2.95e-04 | 36 | 106 | 3 | EFO_0000401, EFO_0003884 | |
| Disease | myelofibrosis (is_implicated_in) | 3.53e-04 | 8 | 106 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | Embryonal Rhabdomyosarcoma | 3.53e-04 | 8 | 106 | 2 | C0206656 | |
| Disease | Acute Promyelocytic Leukemia | 6.11e-04 | 46 | 106 | 3 | C0023487 | |
| Disease | interleukin-6 measurement, response to stimulus | 6.88e-04 | 11 | 106 | 2 | EFO_0004810, GO_0050896 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 7.81e-04 | 50 | 106 | 3 | C0023453 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 8.76e-04 | 52 | 106 | 3 | C0023452 | |
| Disease | creatinine measurement | FOXO3 ATF7 TCF12 BCAS3 ARHGEF18 MED1 NFATC1 ADAMTS7 TNK2 BSN PCK1 | 9.12e-04 | 995 | 106 | 11 | EFO_0004518 |
| Disease | colorectal cancer (is_implicated_in) | 9.68e-04 | 121 | 106 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Common variable immunodeficiency | 9.72e-04 | 13 | 106 | 2 | cv:C0009447 | |
| Disease | ventricular septal defect (is_implicated_in) | 1.13e-03 | 14 | 106 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | bipolar disorder, response to lithium ion | 1.13e-03 | 14 | 106 | 2 | GO_0010226, MONDO_0004985 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.17e-03 | 447 | 106 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | blood urea nitrogen measurement | 1.25e-03 | 452 | 106 | 7 | EFO_0004741 | |
| Disease | Common Variable Immunodeficiency | 1.30e-03 | 15 | 106 | 2 | C0009447 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.39e-03 | 61 | 106 | 3 | C1961102 | |
| Disease | vitamin C measurement | 1.48e-03 | 16 | 106 | 2 | EFO_0600003 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.48e-03 | 16 | 106 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Pontoneocerebellar hypoplasia | 1.48e-03 | 16 | 106 | 2 | cv:C1261175 | |
| Disease | cartilage thickness measurement | 1.88e-03 | 18 | 106 | 2 | EFO_0007873 | |
| Disease | serum non-albumin protein measurement | 1.97e-03 | 361 | 106 | 6 | EFO_0004568 | |
| Disease | JT interval | 2.05e-03 | 248 | 106 | 5 | EFO_0007885 | |
| Disease | cystathionine measurement | 2.10e-03 | 19 | 106 | 2 | EFO_0010474 | |
| Disease | forced expiratory volume | 2.18e-03 | 789 | 106 | 9 | EFO_0004314 | |
| Disease | nasopharyngeal neoplasm | 2.18e-03 | 151 | 106 | 4 | EFO_0004252 | |
| Disease | taurocholate measurement | 2.33e-03 | 20 | 106 | 2 | EFO_0010538 | |
| Disease | Craniosynostosis | 2.33e-03 | 20 | 106 | 2 | C0010278 | |
| Disease | Non-Small Cell Lung Carcinoma | 2.46e-03 | 156 | 106 | 4 | C0007131 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 2.57e-03 | 21 | 106 | 2 | C1292769 | |
| Disease | lymphocyte percentage of leukocytes | 2.78e-03 | 665 | 106 | 8 | EFO_0007993 | |
| Disease | monocyte count | ATF7 ASXL1 TCF3 CDC42BPA BCAS3 CECR2 RIPOR3 RUNX2 SSBP3 NCOR2 YLPM1 TCF7L1 | 2.79e-03 | 1320 | 106 | 12 | EFO_0005091 |
| Disease | hemoglobin change measurement | 2.82e-03 | 22 | 106 | 2 | EFO_0600027 | |
| Disease | Abnormality of refraction | 2.99e-03 | 673 | 106 | 8 | HP_0000539 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.03e-03 | 80 | 106 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | gamma-linolenic acid measurement | 3.35e-03 | 24 | 106 | 2 | EFO_0007762 | |
| Disease | brain stem volume measurement | 3.35e-03 | 24 | 106 | 2 | EFO_0010605 | |
| Disease | hematocrit | 3.50e-03 | 1011 | 106 | 10 | EFO_0004348 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QSMKSPGTTPGPLGR | 456 | Q68DN1 | |
| GKSTGTPSPMSPNPS | 1111 | P51826 | |
| FSSMSLPGAPTASPG | 676 | P27540 | |
| FADFSQMSKPPPSGP | 741 | Q9UBC2 | |
| QMSKPPPSGPFTSSL | 746 | Q9UBC2 | |
| GMTVSQKGGPQPTPS | 346 | Q6ZSZ5 | |
| SGSSQPGDPMRKPGQ | 1616 | Q68CP9 | |
| LMKTLSPGSPSGGPS | 121 | Q17RM4 | |
| PSNRQMGSPTGSLPL | 181 | P17544 | |
| SFPSSRGRNTPGKPM | 3666 | P11532 | |
| GLPYQSPSVPGSMKL | 811 | Q8TEK3 | |
| SQPMPLSKSTPSSGG | 641 | Q9HBB8 | |
| NSVNGTFPAEPMKGP | 6 | P11836 | |
| PPQISPSKSMGGEFC | 566 | Q9H6U6 | |
| EQGLPVFSGSPPMKS | 1281 | Q6W2J9 | |
| TPPPLSSGMGFGSSA | 1341 | Q9BXF3 | |
| PVFPSGKLGPSTNSM | 1331 | Q8IXJ9 | |
| SPASSPKPGTMGNAI | 1031 | Q9UKP4 | |
| PGKTMPTTQSFASDP | 811 | Q07912 | |
| SPQSSMGTSGPPTKL | 141 | Q08708 | |
| SGIKPPGHPFSQMSE | 716 | Q5JR59 | |
| IMSSSPPKFTFPEAG | 311 | Q8NFF2 | |
| VIPFSMGPLGSPLSK | 141 | P35558 | |
| GMKPESGLIQTPSPS | 126 | Q99504 | |
| VPSTPIFSPSMGGGS | 401 | Q92830 | |
| NSLGFSSSPSPIGMP | 611 | Q8TB72 | |
| PQMGTPSPGKGSLTD | 641 | Q8WYB5 | |
| MLKPSGLPGSSSPTR | 1 | Q8WXI7 | |
| GSSPPGGTKPSYTMV | 661 | Q8WXI7 | |
| PSRMGSKSPGNTSQP | 2251 | Q9Y618 | |
| KPSSPSLSPLMGFGS | 361 | Q8TEW8 | |
| PEGTKSTASSPGGPM | 291 | A8MTJ6 | |
| PGGPMLTSTPCLNTF | 301 | A8MTJ6 | |
| IVPGSQLMPSKSPST | 146 | Q13261 | |
| NKMSPSGGAPQTTPT | 1151 | Q9BY89 | |
| GSLPGTSNSMPPLDV | 391 | P42166 | |
| MGSPQARPSSSGPPF | 371 | Q96JK9 | |
| MRLNSSAPGTPGTPA | 1 | P30989 | |
| AMKPPGGESSNLFGS | 16 | Q9H910 | |
| MKQNGGPLTPGTSPT | 1301 | Q9UPA5 | |
| ASKEIGMPFSQGPGT | 1366 | Q9UPA5 | |
| PQTKMEGLPSGTPQS | 1291 | Q9Y6V0 | |
| TASALSTGSPPMKNP | 986 | P56645 | |
| MFSPPVNSGKTRPTT | 26 | Q99081 | |
| MPSTSFPVPSKFPLG | 1 | O95644 | |
| SAGVFMPSTSPKPST | 236 | A1E959 | |
| LFSPTMPCEGKGSPS | 686 | Q93074 | |
| KSFSAGPVMSQGPSV | 691 | P23471 | |
| LHIPGFKPPTSMTGA | 491 | A8MWY0 | |
| QGTLSPPFTQPGGMS | 436 | Q75N03 | |
| GPPKPGSQLDSMLGS | 326 | P49023 | |
| RSQGPTPTLNTGPMK | 886 | Q5VYJ5 | |
| TSKPMGGSAPAKFQP | 1091 | Q14008 | |
| MGTVSKSRASPPGPS | 571 | A4D2P6 | |
| QFPNAEKMTSTTPPG | 1401 | Q9H7D0 | |
| MPVKPSTGSPLVSAN | 326 | Q8WZ74 | |
| MGESSLAPGTLPKPS | 276 | Q5JPI3 | |
| KGLPSPYNMSSAPGS | 2811 | P15924 | |
| TKMAQTNPTPGSLGP | 16 | P05813 | |
| PLSSPQKASPQPMGG | 706 | O75061 | |
| TGPASPSANATTMKP | 896 | Q02246 | |
| SPNFGTVSGLKPASM | 516 | O43303 | |
| APPRSYTPMKGGISN | 61 | Q5VWZ2 | |
| PGLPQTSFSGMGPSA | 946 | Q53TQ3 | |
| MNPSGVKPTPRSGFS | 286 | Q8TBB5 | |
| PSSGMFPQLGTSQTP | 3401 | Q03164 | |
| GPGVMLSKSPSRSSP | 5196 | Q8NDH2 | |
| TSSGLPYGMSVPPEK | 446 | Q9Y467 | |
| VPGTFVGPSTLSPGM | 841 | Q9UJQ4 | |
| ISTLSSPINGMGPPF | 51 | P19793 | |
| SPINGMGPPFSVISS | 56 | P19793 | |
| GFSTGSPQLSSPMNP | 86 | P19793 | |
| GLKIPMTPTSSFVSP | 386 | Q7Z5L9 | |
| GLSPSPGAGMLKTPS | 936 | P80192 | |
| PMSGTTTPTNTFPGG | 556 | Q15648 | |
| MNFKTFSSSPPKPGD | 1351 | Q12923 | |
| MVPASLPGPSNVSGS | 276 | Q5XKR4 | |
| SGGPPVSKAPTMDAQ | 231 | A6NNC1 | |
| TGASGGPPVSKAPTM | 771 | A6NNC1 | |
| GKSFTMQGLPDPPSQ | 96 | Q9P2E2 | |
| PSPTGGLMQRSSSFP | 401 | O43524 | |
| RFSPPSSSLQPGKMS | 26 | Q13950 | |
| ISTAPSKPFPQFMNG | 81 | O15034 | |
| TMINPVPPGGSRSNF | 296 | Q9BWW4 | |
| QESSPMKGPGGPFQL | 246 | Q7Z6J9 | |
| PGPTFQSADLGPTLM | 26 | Q92968 | |
| QTPLMPSFSAPSGTG | 151 | Q96M27 | |
| SISKAQPGAPPSSLM | 136 | Q9Y6Y8 | |
| SSNKLPSFPPFGSMN | 1551 | Q9UHV7 | |
| SGGSYSAKRQPMPSP | 1651 | Q5VT25 | |
| SPMGTASSFPNVGKV | 371 | Q6PIS1 | |
| SPFPVISSSMGSPGL | 131 | P28702 | |
| SVTSGPMSPEGSPSK | 686 | P35612 | |
| RLPMAQFGGTFSPSP | 1871 | Q8IWZ3 | |
| SPKTIAVLPQMGSSP | 386 | Q9BXT8 | |
| NKGPPVGSRISMPTT | 781 | Q6ZU65 | |
| AVSGPMAGKPFRPQS | 271 | Q6ZSR9 | |
| TTGPTGSAPNSPMAL | 236 | P19532 | |
| SFLVSPSPTGKFSMG | 321 | Q96MK2 | |
| ALNSPGPLSPSGMKG | 131 | P15923 | |
| SSGQMGSQPPLLSRP | 531 | Q9HCS4 | |
| IVSQFPGTMAKPPGS | 491 | Q9P246 | |
| PGTMAKPPGSLARSS | 496 | Q9P246 | |
| PIGAMGTPAPKTAFS | 286 | Q76KD6 | |
| PPSTMILSGGTALKP | 2006 | Q5JSZ5 | |
| SPASQKMVIQGPSSP | 1101 | Q12888 | |
| SLSFLPSGVFDGMPP | 661 | Q9NYK1 | |
| PLFPTTASPGGRMNA | 731 | Q9UFB7 | |
| SSGKSTPLKPMFGNS | 566 | Q63HK5 | |
| PVPAQSTFPSKTGGM | 951 | P49750 | |
| PSPGNPSLSKVGTVM | 211 | Q8WYQ9 | |
| TKPLFPSAGQMGTPV | 251 | O43670 | |
| MPEGAQGLSLSKPSP | 1 | Q9H7P9 | |
| PSLAPGTTQPKAMAT | 211 | Q9BZM6 | |
| GQTGMPPSFSKPNIE | 1071 | O94979 | |
| RLGTFPTPSPGSMVQ | 181 | Q96IQ7 | |
| FPAGTKAPSPSQMPG | 1191 | Q9BVV6 | |
| SSGVSIPGPSHQKPM | 4331 | Q5THJ4 | |
| GEPLPIGKPASSMTS | 596 | E9PAV3 |